NOVELLI, Francesco

NOVELLI, Francesco  

BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE  

Mostra records
Risultati 1 - 20 di 261 (tempo di esecuzione: 0.029 secondi).
Titolo Data di pubblicazione Autore(i) File
A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. 2003 COURTOIS G; SMAHI A; REICHENBACH J; DOFFINGER R; CANCRINI C; BONNET M; PUEL A; BESSIA C; NOVELLI F; YAMAOKA S; FEINBERG J; DUPUIS-GIROD S; BODEMER C; LIVADIOTTI S; ROSSI P; FISCHER A; ISRAEL A; MUNNICH A; LE DEIST F; CASANOVA JL
A method and a kit for the in vitro diagnosis of pancreatic ductal adenocarcinoma or for determining the predisposition to pancreatic ductal adenocarcinoma 2012 F. Novelli; M. Capello; P. Cappello
A Mouse To Human Autoantibody Signature in Pancreatic Ductal Adenocarcinoma 2010 Capello Michela; Cappello Paola; Linty Federica; Scarpa Aldo; Pederzoli Paolo; Nisticò Paola; Milella Michele; Novelli Francesco
A new T helper subset producing Interleukin 22 increases in multiplesclerosis patients. 2011 Simona Rolla; Valentina Bardina; Marinella Clerico; Paola Bonaventura; Pietro Quaglino; Giulia Contessa; Luca Durelli; Francesco Novelli
A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1. 1999 BOVOLENTA C; LORINI AL; MANTELLI B; CAMORALI L; F. NOVELLI; BISWAS P; POLI
Abstract 4984: Chemotherapy induces a coordinate autoantibody and T-cell response against tumor-associated antigens in pancreatic cancer patients 2016 Novelli, Francesco; Mandili, Giorgia; Mazza, Emanuela; Bulfamante, Sonia Bulfamante; Giordano, Daniele; Follia, Laura; Cappello, Paola
Abstract B49: Alpha-enolase knockdown reprograms metabolism and points out targetable pathways to counteract PDA growth 2015 Capello, Michela; Ferri-Borgogno, Sammy; Principe, Moitza; Chattaragada, Michelle Samuel; Riganti, Chiara; Zhou, Weidong; Follia, Laura; Liotta, Lance A.; Petricoin, Emanuel F.; Cappello, Paola; Novelli, Francesco
Adenosine A2a receptor stimulation blocks development of nonalcoholic steatohepatitis in mice by multilevel inhibition of signals that cause immunolipotoxicity 2017 Alchera, E;Rolla, S; Imarisio, C; Bardina, V; Valente, G; Novelli, F; Carini, R
Adriamycin-induced proteinuria in nude mice: an immune-system-mediated toxic effect. 1996 A. AMORE; G. MAZZUCCO; F. CAVALLO; G. FORNI; B. GIANOGLIO; M. MOTTA; L. PERUZZI; F. NOVELLI; M. G. PORCELLINI; G. CESANO; R. COPPO.
The advanced glycation end-product Nϵ-carboxymethyllysine promotes progression of pancreatic cancer: implications for diabetes-associated risk and its prevention 2018 Menini, Stefano; Iacobini, Carla; de Latouliere, Luisa; Manni, Isabella; Ionta, Vittoria; Blasetti Fantauzzi, Claudia; Pesce, Carlo; Cappello, Paola; Novelli, Francesco; Piaggio, Giulia; Pugliese, Giuseppe*
Alemtuzumab Long Term Immunological Study: The Immunosuppressive Effect Does Not Last More Than 48 Months 2016 Durelli, L; De Mercanti, S; Rolla, S; Cucci, A; Bardina, V; Cocco, E; Vladic, A; Soldo-Butkovic, S; Habek, M; Adamec, I; Annovazzi, P; Horakova, D; Novelli, F; Clerico, M
Alemtuzumab long-lasting immunological effects: a 48 months follow-up observation 2016 Durelli, L; De Mercanti, SF; Cucci, A; Taverna, D; Rolla, S; Bardina, V; Cocco, E; Vladic, A; Soldo-Butkovic, S; Habek, M; Adamec, I; Horakova, D; Annovazzi, P; Novelli, F; Clerico, M
Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months 2016 De Mercanti, Stefania; Rolla, Simona; Cucci, Angele; Bardina, Valentina; Cocco, Eleonora; Vladic, Anton; Soldo-Butkovic, Silva; Habek, Mario; Adamec, Ivan; Horakova, Dana; Annovazzi, Pietro; Novelli, Francesco; Durelli, Luca; Clerico, Marinella
Alemtuzumab treatment in MS how do the Treg cell function and suppressor cytokine mRNA (IL-10, TGF-beta, IL_27) levels change? 24-month immunological report during 323 and 324 genzyme trials 2012 De Mercanti, S.; Cucci, A.; Viglietti,E.; Giai Via,A.; Taverna, D.; Cimino,D.;Rolla, S.; Bardina,V.; Novelli, F.; Vargas,J.; Gibbin,M.; Piazza,F.; Vladic,A.; Brina.V.; Habek,M.; Cocco,E.; Annavazzi,P.; Horakova,D.; Clerico, M.; Durelli, L.
Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis 2017 Principe, Moitza; Borgoni, Simone; Cascione, Mariafrancesca; Chattaragada, Michelle Samuel; Ferri-Borgogno, Sammy; Capello, Michela; Bulfamante, Sara; Chapelle, Jennifer; Di Modugno, Francesca; Defilippi, Paola; Nisticò, Paola; Cappello, Paola; Riganti, Chiara; Leporatti, Stefano; Novelli, Francesco
Alpha-Enolase (ENO1), a potential target in novel immunotherapies 2017 Cappello Paola; Principe Moitza; Bulfamante Sara; Novelli Francesco
Alpha-enolase elicits specific adenocarcinoma pancreatic-T cell responses in healthy donors and tumor patients 2007 Novelli F; Tomaino B; Ciccarelli M; Capello M; Giovarelli M; Novarino A; Cappello P.
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4. 1994 F. PERICLE; M. GIOVARELLI; M. P. COLOMBO; G. FERRARI; P. MUSIANI; A. MODESTI; F. CAVALLO; F. DI PIERRO; F. NOVELLI; G. FORNI.
AN ISOLATED MONOPHOSPHORYLATED PEPTIDE DERIVED FROM HUMAN ALPHA-ENOLASE USEFUL FOR DIAGNOSIS AND TREATMENT OF PANCREATIC ADENOCARCINOMA, ANTIBODIES DIRECTED AGAINST THE SAID MONOPHOSPHORYLATED PEPTIDE, AND USES THEREOF 2011 F. Novelli; B. Tomaino; P. Cappello
Anti-α-enolase antibody limits the invasion of myeloid-derived suppressor cells and attenuates their restraining effector T cell response 2016 Paola Cappello; Elisabetta Tonoli; Roberta Curto; Daniele Giordano; Mirella Giovarelli; Francesco Novelli